1. Home
  2. FXNC vs ACIU Comparison

FXNC vs ACIU Comparison

Compare FXNC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$28.15

Market Cap

234.3M

Sector

Finance

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.06

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
ACIU
Founded
1907
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.3M
213.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
FXNC
ACIU
Price
$28.15
$3.06
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
37.5K
361.1K
Earning Date
01-29-2026
03-12-2026
Dividend Yield
2.45%
N/A
EPS Growth
96.00
N/A
EPS
1.96
N/A
Revenue
$86,993,000.00
$5,482,957.00
Revenue This Year
$7.52
N/A
Revenue Next Year
$4.47
$644.42
P/E Ratio
$14.15
N/A
Revenue Growth
49.95
N/A
52 Week Low
$18.26
$1.43
52 Week High
$27.80
$4.00

Technical Indicators

Market Signals
Indicator
FXNC
ACIU
Relative Strength Index (RSI) 76.13 41.06
Support Level $25.35 $3.18
Resistance Level $26.00 $3.41
Average True Range (ATR) 0.59 0.25
MACD 0.21 -0.06
Stochastic Oscillator 82.82 5.06

Price Performance

Historical Comparison
FXNC
ACIU

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: